Injective

Injective receives a B- risk grade (34/100) from Hindenrank, where lower scores indicate lower risk. Moderate risk — purpose-built derivatives chain with thin liquidity and a burn model that amplifies both bull and bear cycles A Layer 1 blockchain purpose-built for derivatives trading, with a fully on-chain order book and a weekly token burn funded by trading fees. It holds $74M in TVL with $40M in funding. Its C+ grade reflects thin on-chain liquidity making the order book vulnerable to manipulation, plus an untested MEV-resistance mechanism.

The key risks identified for Injective are: (1) The on-chain order book is much thinner than centralized exchanges. A well-funded attacker can manipulate prices to trigger cascading liquidations of leveraged positions (2) INJ token value depends on weekly token burns funded by trading fees. During bear markets when trading drops, the burns slow down and the scarcity narrative that supports the price collapses (3) The anti-front-running system uses a novel timing mechanism that has never been tested under real adversarial conditions. If it fails, traders can be systematically front-run

Injective scores 34/100 across eight risk dimensions: Mechanism Novelty: 3/15, Interaction Severity: 7/20, Oracle Surface: 5/10, Documentation Gaps: 2/10, Track Record: 3/15, Scale Exposure: 5/10, Regulatory Risk: 3/10, Vitality Risk: 6/10. The highest risk area is Vitality Risk at 6/10.

Among 53 rated Derivatives protocols on Hindenrank, Injective ranks #15 by safety (lowest risk score = safest). Its 34/100 risk score and B- grade place it among the safer Derivatives protocols.

Injective scores 3/15 on the Track Record risk dimension, indicating some history of security incidents or exploits. Higher scores reflect more severe or frequent incidents. Review the full risk report for details.